International Perfusion Association
LivaNova PLC announced the strategic wind down of its Advanced Circulatory Support (ACS) Business Unit to focus on its core Cardiopulmonary and Neuromodulation units, with a complete transition expected by end of 2024. The company will integrate select ACS cannulae products into its Cardiopulmonary unit, while anticipating a positive impact on its 2024 operating income, despite expected restructuring charges.
A review of the top 25 cardiology and cardiovascular medicine journals according to the 2023 SCImago rankings revealed that all allow the use of generative AI in scientific writing within ICMJE limitations, but prohibit AI in authorship, image generation, and peer review processes, requiring authors to take full responsibility for their work. These guidelines are standardized and followed by all studied journals, emphasizing the importance of adhering to and updating these policies to uphold scientific integrity.
This review evaluates the use of Impella and venoarterial extracorporeal membranous oxygenation (VA-ECMO) as strategies to stabilize patients with post-infarct ventricular septal rupture (PIVSR) before surgical repair, based on a case report and a systematic literature review. While both Impella and VA-ECMO have shown better outcomes compared to traditional management, they present unique advantages and challenges; Impella effectively unloads the left ventricle but may cause shunt reversal, whereas VA-ECMO improves organ perfusion but has higher complication risks and may require additional ventricular unloading.
